Douglas Schirle
Analyst · Baird
Thank you, Lee-Lean. We reported net income of $1.1 million or $0.04 per diluted share on net revenues of $16 million for our second fiscal quarter ended September 30, 2012, compared to net income of $1.7 million or $0.06 per diluted share, and net revenues of $20.8 million in the comparable period a year ago.
In the quarter ended June 30, 2012, we were $920,000 or $0.03 per diluted share on net revenues of $16.8 million. For the 6 months ended September 30, 2012, net income was $2.1 million or $0.07 per diluted share, net revenues of $32.8 million, compared to net income of $4.9 million or $0.16 per diluted share on net revenues of $43.8 million in the first 6 months of fiscal 2012. Gross margin was 42.6% compared to 43.9% in the comparable period of fiscal 2012.
Second quarter direct and indirect sales to Cisco Systems were $4.9 million or 30.6% of net revenues, compared to $4.1 million or 24.2% of net revenues in the prior quarter, and $7.9 million or 38% of net revenues the same period a year ago.
Military/defense sales, which vary considerably from quarter-to-quarter, were 7.4% of shipments, compared to 11.9% of shipments the prior quarter, 10% of shipments in the comparable period a year ago. SigmaQuad sales were 33.9% of shipments compared to 38% in the prior quarter, and 35.4% in the second quarter of fiscal 2012.
Second quarter operating income was $1.5 million, or 9.4% of net revenues, compared to $880,000, or 5.2% of net revenues in the prior quarter, and $1.9 million or 9.2% of net revenues a year ago. Total operating expenses were $5.7 million compared to $5.9 million in the prior quarter and $7.1 million from the second quarter of fiscal 2012.
Second quarter research and development expense was $2.9 million, compared to $2.8 million from the prior quarter, and $2.7 million a year ago. Second quarter selling, general and administrative expense of $2.8 million included $323,000 in litigation-related expenses, compared to SG&A of $3 million in the prior quarter, when litigation-related expenses were $455,000. Year ago, SG&A of $4.4 million included $1.9 million in litigation-related expenses. These litigation-related expenses are primarily associated with a patent infringement proceeding pending before the United States International Trade Commission, which was instituted in response to a complaint filed by Cypress Semiconductor Corp. in June 2011, and a related antitrust lawsuit brought by GSI against Cypress in July 2011. Total second quarter pre-tax stock-based compensation expense was $560,000 compared to $562,000 from the prior quarter and $515,000 in the comparable quarter a year ago.
In September 30, 2012, we had $67.1 million in cash, cash equivalents and short-term investments, and $26.1 million in long-term investments, $91.7 million in working capital, no debt and stockholders equity of $129.2 million.
Accounts payable at September 30 was $3.8 million, down from $5.5 million at March 31. Net inventory was $17.3 million at September 30, down from $16.7 million at March 31. Inventory turns at September 30 are 2.0x, compared to 2.4x at March 31.
Depreciation and amortization expense was $633,000 for the quarter. Under our expanded repurchase program, we're authorized to repurchase up to a total of $20 million of our common stock, from time to time, on the open market, for private transactions. The specific timing and the amount of repurchases will be dependent on market conditions, securities laws limitations and other factors. The repurchase program may be suspended or terminated at any time without prior notice. During the quarter ended September 30, 2012, we repurchased 286,232 shares at an average cost of $4.68 per share. To date, we have repurchased a total of 3,533,792 at an average cost of $3.86 per share for a total cost of $13.6 million.
We currently expect net revenues in the third quarter of fiscal 2013 to be in the range of $15 million to $16 million, with gross margin of approximately 43%. We also expect our ongoing legal expenses related to patent litigation and antitrust litigation will continue to affect our operating income and our bottom line. These expenses are difficult to forecast, but we currently estimate that they will be approximately $1.1 million in the third quarter. Operating expenses, in total, are expected to be approximately $6.6 million.
Operator, at this point, we'll open the call to Q&A.